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Abstract
Squamous cell carcinoma is the most common head and neck cancer. This review describes the state-of-the-art compu-
terised tomography and magnetic resonance imaging protocols of the neck and the normal larynx anatomy, and provides a
practical approach for the diagnosis and staging of laryngeal squamous cell carcinoma.
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Introduction
Laryngeal cancer is one of most common head and
neck cancer.1 Squamous cell carcinoma (SCC) accounts
for the majority of cases.2 Other, less common, tumours
include chondrosarcoma, metastases and non-
Hodgkin’s lymphoma.2
SCC is most common in the ﬁfth to seventh decades
of life.3 The male-to-female ratio is 3.83:1.3 Moderate
or heavy alcohol consumption and smoking are the
main risk factors for SCC.4 Workplace exposure to
wood dust and paint fumes also increases the risk for
SCC.4 An association between laryngeal tumour and
human papilloma virus infection has also been
reported.5
Unlike most non-squamous cell tumours, which are
submucosa-based lesions, SCCs arise from the mucosa
and, therefore, can be easily visualised at laryngoscopy,
and biopsied.6,7
The principal role of radiologic examinations is to
evaluate deep tumour extent and anatomic relation-
ship with surrounding structures, which can be
missed at endoscopy and physical examination.
Moreover, radiologic examinations allow simultan-
eous evaluation of neck lymph nodes and distant
metastases.
In this paper, we will describe the state-of-the-art
computerised tomography (CT) and magnetic reson-
ance imaging (MRI) protocols, the normal larynx anat-
omy, and we oﬀer a practical approach for diagnosis
and staging of laryngeal SCC.
Imaging techniques
Radiologic evaluation of the larynx usually starts with
CT because of short scanning time, excellent anatomic
resolution, and wide availability. MRI is reserved for
select cases, when CT results are not conclusive. Due to
its excellent soft-tissue resolution, MRI is more accur-
ate than CT in delineating deep tumour extension and
cartilage involvement.
Image quality strongly depends on patient cooper-
ation. At our hospital, patients are instructed not to
swallow or cough during the acquisition in order to
prevent or minimise motion-related artifacts before
scanning.
CT. CT of the neck extends from the skull base to the
inferior aortic arch. Patients are placed in the supine
position, with the neck slightly extended.8 Intravenous
contrast material is routinely used because it improves
the delineation of the tumour extent and detection of
neck lymph nodes. A delay of 50–75 s allows an
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adequate enhancement of primary tumour and an accu-
rate diﬀerentiation of cervical lymph nodes from ves-
sels.9 Demonstration of suﬃcient attenuation of neck
vessels suggests good image quality.10 Unenhanced
images are not routinely acquired to reduce patient
exposure to ionising radiations. At our hospital, unen-
hanced images are acquired only during the ﬁrst CT
examination.
A correct reformation plane orientation is crucial for
avoiding misinterpretation. Axial images must be par-
allel to the true vocal cords or the hyoid bone, while
coronal images must be parallel to the airways and
orthogonal to the true vocal cords. Recognition of the
true vocal cords is facilitated by the identiﬁcation of the
arythenoid cartilages.
Images are viewed using both soft-tissue (window
width, 250–350 HU; window centre, 50 HU) and
bone window-settings (window width, 2000 HU;
window centre, 600 HU), the latter helps to evaluate
cartilage invasion. Slice thickness is 2mm with an over-
lapping reconstruction interval of 1mm.
Multiplanar-reformatted (MPR) images in coronal
and sagittal planes allow a more conﬁdent evaluation
of the anatomic relationship between the tumour and
the surrounding structures.
MRI. Magnetic resonance (MR) images are acquired
using an anterior surface head and neck coil. Scan
extent and patient position are similar to CT. The
basic MRI protocol consists of axial and sagittal unen-
hanced T1 turbo spin echo (TSE) weighted sequences,
axial fat-suppressed T2-weighted TSE sequence, axial
diﬀusion-weighted sequence, and axial and coronal fat-
suppressed T1-weighted TSE sequences obtained before
and after gadolinium injection. Slice thickness is 2–
4mm, with no interslice gap. Similarly to CT, axial
images must be parallel to the true vocal cords. To
obtain the correct orientation, MR examination
should start with the acquisition of an unenhanced
sagittal T1-weighted sequence, which helps identify
the larynx and the plane of the true vocal cords. Since
fat shows bright signal intensity, unenhanced T1-
weighted images also help delineate tumoral invasion
of fat planes.
T2-weighted sequences are used to detect intratu-
moral cystic areas and evaluate deeper tumour spread.
DWI sequences are useful in detecting and charac-
terising laryngeal mass, and in diﬀerentiating malignant
from benign cervical lymph nodes.11 Moreover, DWI
seems to be promising in diﬀerentiating benign post-
treatment changes and residual or recurrent
tumour.12,13
Intravenous contrast material administration is
strongly recommended because it increases tumour
conspicuity, helps diﬀerentiate necrotic and cystic
areas from viable tumour, and improves the evaluation
of soft tissue and perineural invasion.14 Fat saturation
is essential in diﬀerentiating enhancing tumour from
surrounding fat.
The use of a 3D fat-suppressed T1-weighted gradient
echo (GRE) sequence (VIBE (Siemens Healthcare),
LAVA (GE Healthcare) and THRIVE (Philips
Healthcare)) taking approximately 30 s reduces the
long acquisition times of traditional spin echo (SE) or
fast SE sequences (several minutes) without degrading
image quality, and motion artifacts.15
Anatomy of the larynx
Familiarity with the anatomy of the larynx, and the
routes of spread of SCC is crucial in assigning the cor-
rect stage.
The larynx is anatomically divided into three parts:
the supraglottis, glottis and subglottis (Figure 1).
The glottis and supraglottis are the most common
sites of origin of SCC, and account for approximately
60% and 35% of cases, respectively. The remaining
origins are in the subglottis or involve more than one
area.1 In the latter case, the tumour is classiﬁed as
transglottic.
The supraglottis is the upper part of the larynx,
and extends from the tip of the epiglottis to the
laryngeal ventricles. Above the tip of the epiglottis
is the oropharinx. The supraglottis includes the epi-
glottis, aryepiglottic folds, false vocal cords, and lar-
yngeal ventricles. The glottis is located between the
supraglottis and subglottis. It is bordered superiorly
by the upper margin of the true vocal cords, and
inferiorly by a plane 1 cm below the ventricles.
The supraglottis contains the true vocal cord, and
anterior and posterior commissures. The arytenoids
cartilages are an useful anatomic landmark to diﬀer-
entiate the glottis from the supraglottis. Indeed, the
superior board lies at the level of the false vocal
cords, while the vocal process lies at the level of
the true vocal cords.
The subglottis is the lower part of the larynx, and is
separated by the trachea from the lower margin of the
cricoid cartilage, which is easy to identify because it is
the only laryngeal cartilage that forms a complete ring.
Diagnosis of SCC
The normal larynx wall is usually thin and
symmetric. Any asymmetric thickening of the
laryngeal wall should raise the suspicion of SCC
(Figure 2 and 3).
At CT, SCCs usually show slight to moderate
enhancement, which helps delineate tumour margins
and evaluate deep tumour extension.9
At MR, SCCs show a characteristic T2-hyperinten-
sity and T1-hypointensity. The former helps diﬀerenti-
ate the tumour from hypointense muscle, while the
latter helps diﬀerentiate the tumour from hyperintense
fat.14 Hyperintensity on high-b-value diﬀusion-
weighted images, and hypointensity on the apparent
diﬀusion coeﬃcient (ADC) map help detect the
tumour, and conﬁrm its solid nature.16
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SCC staging
SCC of the larynx is staged using the TNM cri-
teria, which are endorsed by the American Joint
Committee on Cancer Staging.17 The T stage is
based on tumour size and local extent, while the
presence and location of regional nodal
metastases deﬁne the N stage. The M stage indi-
cates the presence or absence of haematogeneous
metastases.
Figure 1. Anatomy of the larynx. AEF: aryepiglottic fold; CC: cricoid cartilage; E: epiglottis; HB: hyoid bone; LV: laryngeal ventricle; TVC:
true vocal cords; TC: thyroid cartilage; V: vallecula.
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Local tumour spread. In addition to diagnosing an SCC,
the radiologist should deﬁne its relationship to sub-
mucosal spaces, laryngeal cartilages and extra-laryngeal
soft-tissues, because their involvement can preclude
conservative surgery and radiation therapy.
The submucosal pre-epiglottic and paraglottic
spaces are critical structures for the spread of SCC.
Invasion of these spaces upstages SCC to T3 stage,
thus inﬂuencing treatment choice.
The pre-epiglottic space is a triangular, fat-ﬁlled area
located between the epiglottis (posteriorly) and the
hyoid bone (anteriorly). The paraglottic spaces are
located lateral to the true and false vocal cords, and
contain fat and muscle. Of note, pre-epiglottic and
paraglottic spaces cannot be visualised at laryngoscopy.
The primary sign of submucosal invasion at CT and
MRI is an enhancing tumour within the submucosal
spaces (Figure 4). Demonstration of replacement of
T1-hypentense fat from hypo-intense tumour usually
corroborates the diagnosis.
The presence of cartilage invasion indicates a T4
stage.17 The imaging appearance of the laryngeal carti-
lages depends on the degree of mineralisation. At CT,
cortical ossiﬁed cartilage shows bone attenuation, while
medullary fat and non-ossiﬁed cartilage show low
attenuation. Tumour invasion can be suspected only in
the presence of tumour proximity to the cartilage and
asymmetric sclerosis of the cartilage surface18 (Figure 5).
MRI shows higher sensitivity than CT in the detec-
tion of cartilage tumour invasion.18 Normal cartilages
show variable signal intensity on T1- and T2-weighted
images, depending on the degree of cartilage minerali-
sation, and no enhancement.18,19 Invaded cartilage
show intermediate T2-signal intensity and variable
enhancement.18,19
A similar cartilage MRI appearance, however, can
be due to peri-tumoral inﬂammation and reduces MRI
speciﬁcity.18,19 Comparison with signal intensity of the
primary tumour helps in the diﬀerential diagnosis:
invaded cartilage shows T2-signal intensity and
enhancement similar to that of the primary tumour,
while inﬂamed cartilage shows T2-signal intensity and
enhancement higher than that of the primary tumour.19
Lymphatic spread. Cervical lymph node metastasis is the
main mechanism of the spread of SCC. Cervical nodes
are located according to the classiﬁcation of the
American Head and Neck Society and the American
Academy of Otolaryngology-Head and Neck
Surgery.20 This classiﬁcation divides cervical nodes
into six levels on the basis of the primary lymphatic
drainage of each cervical tumour. Knowledge of
nodal drainage patterns helps radiologists to correctly
characterise enlarged nodes, and to accurately evaluate
the most likely sites of metastasis.21 Indeed, the supra-
glottis drains primarily into the upper jugular lymph
nodes, while the glottis and subglottis have a sparse
lymphatic drainage.21 These diﬀerences are due to the
diﬀerent embryologic origins of the supraglottis with
respect to those of the glottis and subglottis.21
Figure 2. Axial contrast-enhanced computerised tomography (CT) image obtained in a 56-year-old man with glottic squamous cell
carcinoma (SCC) shows asymmetric thickening of the left true vocal cordal (arrowhead).
200 The Neuroradiology Journal 30(3)
CT and MRI show higher accuracy than clinical
examination in the detection of cervical lymph node
metastasis.
The presence, number, site, and size of lymph node
metastasis reﬂect tumour aggressiveness, and inﬂuence
treatment choices.
Traditional criteria to diﬀerentiate normal and
pathologic nodes include size, shape, margins and
enhancement. Diﬀusion-weighted imaging is a promis-
ing technique to detect metastatic cervical node.
An enlarged cervical node should always raise the
suspicion of metastasis (Figure 6). As a general rule,
the smaller the size, the higher the likelihood of benig-
nity. Several size cut-oﬀs to diﬀerentiate normal from
pathologic cervical nodes have been reported in the
literature, and range between 5–30mm.21 For instance,
the Response Evaluation Criteria in Solid Tumors
(RECIST) version 1.1 criteria use the node short-axis
diameter on axial CT and MR images. Nodes with
short-axis diameter of <10mm are considered benign,
while those with a short-axis diameter of >15mm are
considered malignant.22 An optimal size cut-oﬀ, how-
ever, does not exist. Indeed, reactive lymph nodes can
be enlarged due to hyperplasia and inﬂammation, and
small lymph nodes can be pathologic due to micro-
scopic metastatic deposits.23 At our hospital, a cut-oﬀ
short-axis diameter of 10mm is used as suggested by
Van den Brekel et al.23
Figure 3. Coronal contrast-enhanced computerised tomography (CT) image obtained in a 65-year-old man shows a trans-glottic squa-
mous cell carcinoma (SCC) (arrow) involving the true and false right vocal cord.
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Figure 4. Axial contrast-enhanced computerised tomography (CT) image obtained in a 55-year-old man with supra-glottic squamous cell
carcinoma (SCC) shows tumour invasion of the pre-epiglottic space (arrow).
Figure 5. Axial contrast-enhanced computerised tomography (CT) images ((a) soft-tissue window, (b) bone window) obtained in a 76-
year-old man with squamous cell carcinoma (SCC) of the right true vocal cord shows asymmetric sclerosis of the vocal process of the
arytenoid cartilage (arrow) due to invasion of the tumour (arrowhead).
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Benign lymph nodes are typically oval- or ﬂat-
shaped, while malignant lymph nodes tend to be
round. A longitudinal-to-axial largest diameter ratio
equal to or greater than two suggests a benign lymph
node.24
Benign lymph nodes show well-deﬁned margins.21
Ill-deﬁned margins are a hallmark of malignancy and
indicate extra-capsular tumour spread.21
Benign lymph nodes show a characteristic homoge-
neous enhancement, except for the hypoattenuating/
intense fatty hilum, while metastatic nodes show a het-
erogeneous enhancement due to necrosis, haemorrhage
or cystic degeneration.21
Several studies have demonstrated that metastatic
lymph nodes have a lower ADC values than benign
lymph nodes due to their increased cellularity.25–27 De
Bondt et al. have reported that the use of ADC values
in combination with the traditional imaging criteria
improves the diﬀerentiation of malignant and benign
lymph nodes.25 It should be kept in mind, however,
that reactive lymph nodes can sometimes show low
ADC values due to a large amount of inﬂammatory
cells and a ﬁbrotic stroma.28 In addition to diagnosing
a lymph node metastasis, the radiologist should evalu-
ate its relationship with surrounding structures such as
carotid artery, muscle and bone since their involvement
can preclude surgery. Carotid artery invasion should be
suspected in presence of loss of fat plane; wall irregu-
larity, vessel deformation and >180–270 circumferen-
tial encasement.29
Haematogeneous spread. Haematogeneous metastases
are uncommon, and are usually due to recurrent dis-
ease.30,31 Risk factors include clinically palpable neck
lymph nodes, histological evidence of nodal metastasis
and extracapsular spread.30–32 The lung is the most
common site, representing 66% of haematogeneous
metastases.31 Diﬀerential diagnosis between lung
metastasis from SCC and synchronous primary SCC
is not easy (Figure 7). Other sites include the bone,
liver, skin, mediastinum and bone marrow.31 Pre-and
post-operative CT screening for distant metastases for
distant metastases should be performed only in high-
risk patients.
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Figure 6. Axial magnetic resonance images obtained in a 66-year-old man with subglottic squamous cell carcinoma (SCC) and enlarged
lymph node metastases in the level IIa and b on the right side. (a) On T2-weighted turbo spin echo (TSE) image, lymph node metastases
(arrows) show heterogeneous hyperintesity. (b) On b800 diffusion-weighted image lymph node metastases show strong hyperintesity. (c)
On contrast-enhanced T1-gradient echo (GRE) image lymph node metastases show heterogeneous enhancement.
Figure 7. Axial contrast-enhanced computerised tomography (CT)
image obtained in a 68-year-old-man with glottic squamous cell
carcinoma (SCC) and synchronous SCC of the lung shows a large
mass in the superior lobe of the right lung. Diagnosis of primary
SCC of the lung was done after biopsy and collegial revision.
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